Cargando…
The Prediction of Response to Galantamine Treatment in Patients with Mild to Moderate Alzheimer’s Disease
The prediction of efficacy in long-term treatment of acetylcholinesterase inhibitors (AChEIs) is a major clinical issue, although no consistently strong predictive factors have emerged thus far. The present analyses aimed to identify factors for predicting long-term outcome of galantamine treatment....
Autores principales: | Ohnishi, Takashi, Sakiyama, Yojiro, Okuri, Yuichi, Kimura, Yuji, Sugiyama, Nami, Saito, Takayuki, Takahashi, Masayoshi, Kobayashi, Takumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979115/ https://www.ncbi.nlm.nih.gov/pubmed/24156269 http://dx.doi.org/10.2174/15672050113106660167 |
Ejemplares similares
-
Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Seltzer, Ben
Publicado: (2010) -
Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug naïve patients with mild-to-moderate Alzheimer's disease
por: Peters, Oliver, et al.
Publicado: (2015) -
Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil
por: Hwang, Tae-Young, et al.
Publicado: (2016) -
The Effects of Galantamine Treatment on Attention and Its Relationship with Cognition and Activities of Daily Living in Patients with Mild to Moderate Alzheimer's Disease
por: Lee, Jae-Hong, et al.
Publicado: (2015) -
Long-Term Response to Galantamine in Relation to Short-Term Efficacy Data: Pooled Analysis in Patients with Mild to Moderate Alzheimer’s Disease
por: Kavanagh, S, et al.
Publicado: (2011)